In 2023 Salus Group has reached a significant milestone, achieving a revenue of €600 million. This marks an impressive growth of 20% and underscores our commitment to excellence and innovation in the healthcare sector. This success wouldn’t have been possible without the dedication and hard work of our exceptional teams and partners across the CEE markets.
The year 2023 was transformative for Salus Group, highlighted by two strategic acquisitions that have strengthened our position in the CEE region. These acquisitions have expanded our portfolio, particularly in Rare Disease therapies and cutting-edge Diagnostic innovations, aligning perfectly with our mission to enhance access to innovative treatments and make a tangible difference in the lives of patients in need.
Together, we will continue to pioneer new advancements, transform healthcare, and improve outcomes for patients across our region.
